Microbot Medical (NASDAQ:MBOT) Stock Price Crosses Above 200-Day Moving Average – Here’s What Happened

Microbot Medical Inc. (NASDAQ:MBOT) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.98 and traded as high as $1.01. Microbot Medical shares last traded at $1.00, with a volume of 304,319 shares.

Microbot Medical Stock Up 0.3 %

The company has a market cap of $16.93 million, a P/E ratio of -1.25 and a beta of 1.62. The company has a 50 day moving average price of $0.97 and a 200-day moving average price of $0.98.

Institutional Investors Weigh In On Microbot Medical

A hedge fund recently bought a new stake in Microbot Medical stock. Thoroughbred Financial Services LLC purchased a new position in Microbot Medical Inc. (NASDAQ:MBOT) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 52,250 shares of the biotechnology company’s stock, valued at approximately $53,000. Thoroughbred Financial Services LLC owned about 0.33% of Microbot Medical at the end of the most recent quarter. 16.30% of the stock is currently owned by hedge funds and other institutional investors.

About Microbot Medical

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.